As HIF-1α signaling could be regulated by ATP-associated signaling, we combined S3I-201 and LY294002 to co-target the upstream signaling components of the ATP-HIF-1α signaling pathway, and our in vivo mouse model showed increased drug sensitivity of cancer cells to chemotherapy. Here, HIF1A is linked to cancer.